s-nitrosoglutathione has been researched along with Disease Models, Animal in 42 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.38) | 18.2507 |
2000's | 10 (23.81) | 29.6817 |
2010's | 29 (69.05) | 24.3611 |
2020's | 2 (4.76) | 2.80 |
Authors | Studies |
---|---|
Einisman, HJ; Gaston, B; Lewis, SJ; Lewis, TH; Raffay, TM; Smith, LA; Wijers, C | 1 |
Li, C; Lu, F; Yan, JZ; Yang, Q; Yin, XH; Yu, LM; Zhang, TY | 1 |
Dhammu, TS; Khan, M; Kumar, P; Qiao, F; Singh, AK; Singh, I | 1 |
da Silva, LCE; de Araújo, EP; de Oliveira, MG; Dos Santos, GJVP; Jara, CP; Picheth, GF; Póvoa, VCO | 1 |
Douglass, M; Handa, H; Hopkins, S; Norman, M; Pandey, R; Singha, P | 1 |
Dubey, H; Gulati, K; Ray, A | 1 |
Dhammu, TS; Khan, H; Khan, M; Shunmugavel, A; Singh, AK; Singh, I | 1 |
Cao, J; Hasan, N; Hlaing, SP; Jhun, BH; Jung, Y; Kim, J; Lee, BL; Lee, EH; Lee, J; Naeem, M; Shin, JH; Yoo, JW | 1 |
Abrahamsohn, Ide A; Costa, IS; de Oliveira, MG; de Souza, GF | 1 |
Hou, XY; Wu, SL; Yan, JZ; Yin, XH; Zhang, GY | 1 |
Annex, BH; Call, JA; Donet, JA; French, BA; Lira, VA; Martin, KS; Okutsu, M; Peirce-Cottler, SM; Rembold, CM; Yan, Z; Zhang, M | 1 |
Catharino, RR; de Oliveira, MG; de Souza, GF; Duarte, DA; Ferreira, MS; Lopes de Faria, JB; Lopes de Faria, JM; Rosales, MA; Silva, KC | 1 |
Baldim, V; Braga, CM; Brito, GA; Cavalcante, MM; Colombo, AP; de Oliveira, MG; Holanda-Afonso, RC; Leitão, RF; Moura-Neto, V; Ribeiro, RA; Silva-Boghossian, CM; Skeff, MA | 1 |
Annamalai, B; Choi, S; Singh, AK; Singh, I; Won, JS | 2 |
Dhammu, TS; Khan, M; Matsuda, F; Singh, AK; Singh, I | 1 |
Annamalai, B; Dhammu, TS; Dhindsa, TS; Khan, M; Matsuda, F; Singh, AK; Singh, I | 1 |
Bisson, JF; Boudier, A; Dupuis, F; Lartaud, I; Maincent, P; Parent, M; Perrin, J; Vigneron, C; Violle, N | 1 |
Hao, LY; Qi, SH; Wei, XW | 1 |
Baldim, V; Bonfim, LE; Brito, GA; Costa, DV; G de Oliveira, M; Leitão, RF; Lima, V; Martins, CS; Melo, CB; Melo, IM; Santos, GS; Wong, DV | 1 |
Guo, P; Hao, L; Qi, S; Wei, X; Zhang, G | 1 |
Crawford, RW; Friis, TE; Liao, W; Masci, PP; Wang, X; Xiao, Y | 1 |
Baarine, M; Dhammu, TS; Khan, M; Kim, J; Paintlia, MK; Singh, AK; Singh, I | 1 |
Aggrawal, N; Agrawal, N; Ahmad, AS; Cascio, MB; Doré, S; Ehmsen, JT; Hara, MR; Hester, L; Kamiya, A; Sawa, A; Sen, N; Snyder, SH | 1 |
Audoly, LP; Ito, S; Katano, T; Kunori, S; Matsumura, S; Okuda-Ashitaka, E; Urade, Y | 1 |
Foster, MW; Michael Foster, W; Potts, EN; Que, LG; Yang, Z | 1 |
Blonder, JP; Colagiovanni, DB; Green, LS; Mutka, SC; Qiu, J; Richards, JP; Rosenthal, GJ; Stout, AM; Strong, SA; Sun, X; Wasley, JW | 1 |
de Carvalho Leitão, RF; de Castro Brito, GA; de Menezes, AM; de Oliveira, MG; de Souza, GF; Gomes, AS; Ribeiro, Rde A | 1 |
Cabrales, P; Carvalho, LJ; Frangos, JA; Martins, YC; Zanini, GM | 1 |
Dhammu, TS; Khan, M; Sakakima, H; Shunmugavel, A; Singh, AK; Singh, I; Yoshida, Y | 1 |
Dhammu, TS; Gilg, AG; Khan, M; Sakakima, H; Shunmugavel, A; Singh, AK; Singh, I | 1 |
Annamalai, B; Kim, J; Shunmugavel, A; Singh, AK; Singh, I; Won, JS | 1 |
Ikebe, K; Irie, H; Kato, T; Oniki, Y; Takagi, K; Tsuchida, T; Yamaga, M | 1 |
Guibert, EE; Quintana, A; Rodriguez, JV; Scandizzi, A | 1 |
Ayasolla, K; Elango, C; Gilg, AG; Giri, S; Jatana, M; Khan, M; Sekhon, B; Singh, AK; Singh, I | 1 |
Alonso-Escolano, D; Drews, M; Jurasz, P; Malinski, T; Morandi, M; Radomski, A; Radomski, MW | 1 |
Giri, S; Nath, N; Prasad, R; Singh, AK; Singh, I | 1 |
Crosson, CE; Haq, E; Nath, N; Rohrer, B; Singh, I | 1 |
Carvalheira, JB; Carvalho-Filho, MA; Cintra, DE; De Souza, CT; Moraes, JC; Pauli, JR; Ropelle, ER; Saad, MJ; Velloso, LA | 1 |
Amadeu, TP; de Oliveira, MG; Monte-Alto-Costa, A; Seabra, AB | 1 |
Hurst, T; Johnson, D; Mayers, I; Radomski, MW; Salas, E | 1 |
Fang, FC; Killoran, PB; Lu, S; Riley, LW | 1 |
42 other study(ies) available for s-nitrosoglutathione and Disease Models, Animal
Article | Year |
---|---|
Tracheomalacia in bronchopulmonary dysplasia: Trachealis hyper-relaxant responses to S-nitrosoglutathione in a hyperoxic murine model.
Topics: Animals; Asthma; Bronchodilator Agents; Bronchopulmonary Dysplasia; Disease Models, Animal; Humans; Hyperoxia; Infant, Newborn; Methacholine Chloride; Mice; Muscle, Smooth; S-Nitrosoglutathione; Signal Transduction; Trachea; Tracheomalacia | 2019 |
Denitrosylation of nNOS induced by cerebral ischemia-reperfusion contributes to nitrosylation of CaMKII and its inhibition of autophosphorylation in hippocampal CA1.
Topics: Animals; CA1 Region, Hippocampal; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Disease Models, Animal; Dizocilpine Maleate; Indazoles; Male; Nitric Oxide; Nitric Oxide Synthase Type I; Phosphorylation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; S-Nitrosoglutathione | 2019 |
S-Nitrosoglutathione Mimics the Beneficial Activity of Endothelial Nitric Oxide Synthase-Derived Nitric Oxide in a Mouse Model of Stroke.
Topics: Alcohol Dehydrogenase; Animals; Behavior, Animal; Benzamides; Brain; Brain Edema; Disease Models, Animal; Enzyme Inhibitors; Infarction, Middle Cerebral Artery; Male; Mice, Inbred C57BL; Mice, Knockout; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase Type III; Pyrroles; S-Nitrosoglutathione | 2019 |
Wound healing action of nitric oxide-releasing self-expandable collagen sponge.
Topics: Animals; Collagen; Disease Models, Animal; Drug Implants; Male; Mice; Nitric Oxide; S-Nitrosoglutathione; Wound Healing; Wounds and Injuries | 2020 |
S-Nitrosoglutathione-Based Nitric Oxide-Releasing Nanofibers Exhibit Dual Antimicrobial and Antithrombotic Activity for Biomedical Applications.
Topics: Animals; Anti-Infective Agents; Disease Models, Animal; Drug Liberation; Fibrinolytic Agents; Humans; Hydroxybutyrates; Mice; Nanofibers; NIH 3T3 Cells; Nitric Oxide; Platelet Adhesiveness; Polyesters; Prohibitins; S-Nitrosoglutathione; Staphylococcal Infections; Staphylococcus aureus; Swine; Thrombosis; Wound Healing | 2021 |
Amelioration by nitric oxide (NO) mimetics on neurobehavioral and biochemical changes in experimental model of Alzheimer's disease in rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Hippocampus; Male; Maze Learning; Motor Activity; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Donors; Peptide Fragments; Rats, Wistar; S-Nitrosoglutathione; Streptozocin | 2018 |
Combined treatment with GSNO and CAPE accelerates functional recovery via additive antioxidant activities in a mouse model of TBI.
Topics: Amino Acid Oxidoreductases; AMP-Activated Protein Kinases; Animals; Antioxidants; Behavior Rating Scale; Brain Injuries, Traumatic; Caffeic Acids; Disease Models, Animal; Drug Synergism; Dynamins; GTP Phosphohydrolases; Heme Oxygenase-1; Membrane Proteins; Mice; Mice, Inbred C57BL; Mitochondria; Mitochondrial Proteins; Neurons; Neuroprotective Agents; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phenylethyl Alcohol; Protein Serine-Threonine Kinases; S-Nitrosoglutathione; Superoxide Dismutase | 2018 |
S-Nitrosoglutathione loaded poly(lactic-co-glycolic acid) microparticles for prolonged nitric oxide release and enhanced healing of methicillin-resistant Staphylococcus aureus-infected wounds.
Topics: Animals; Anti-Bacterial Agents; Delayed-Action Preparations; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Male; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred ICR; Microscopy, Electron, Scanning; Microspheres; Nitric Oxide; Nitric Oxide Donors; Polylactic Acid-Polyglycolic Acid Copolymer; S-Nitrosoglutathione; Staphylococcal Infections; Time Factors; Wound Healing; X-Ray Diffraction | 2018 |
S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions.
Topics: Administration, Topical; Animals; Antiparasitic Agents; Disease Models, Animal; Female; Leishmania braziliensis; Leishmania major; Leishmaniasis, Cutaneous; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Parasite Load; S-Nitrosoglutathione; Skin; Treatment Outcome; Ulcer | 2013 |
Neuroprotection of S-nitrosoglutathione against ischemic injury by down-regulating Fas S-nitrosylation and downstream signaling.
Topics: Animals; Brain Ischemia; CA1 Region, Hippocampal; Caspase 3; Caspase 8; Caspase 9; Disease Models, Animal; Down-Regulation; Fas Ligand Protein; fas Receptor; Indazoles; Male; Neurons; Neuroprotective Agents; Nitric Oxide Synthase Type I; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Reperfusion Injury; S-Nitrosoglutathione; Signal Transduction | 2013 |
Extracellular superoxide dismutase ameliorates skeletal muscle abnormalities, cachexia, and exercise intolerance in mice with congestive heart failure.
Topics: Animals; Antioxidants; Cachexia; Creatine Kinase, MM Form; Disease Models, Animal; Exercise Tolerance; Heart Failure; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Muscle Proteins; Muscle, Skeletal; Physical Conditioning, Animal; RNA, Messenger; S-Nitrosoglutathione; SKP Cullin F-Box Protein Ligases; Superoxide Dismutase | 2014 |
S-nitrosoglutathione inhibits inducible nitric oxide synthase upregulation by redox posttranslational modification in experimental diabetic retinopathy.
Topics: Analysis of Variance; Animals; Biomarkers; Cell Line; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Electroretinography; Glial Fibrillary Acidic Protein; Glutathione; Humans; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Ophthalmic Solutions; Rats; Reactive Oxygen Species; Retina; S-Nitrosoglutathione; Tyrosine; Up-Regulation | 2014 |
S-nitrosoglutathione accelerates recovery from 5-fluorouracil-induced oral mucositis.
Topics: Administration, Topical; Animals; Cricetinae; Disease Models, Animal; Fluorouracil; Gene Expression Regulation, Neoplastic; Humans; Inflammation; Interleukin-1beta; Male; Neoplasms; Nitric Oxide Synthase Type II; S-Nitrosoglutathione; Stomatitis; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2014 |
Role of S-nitrosoglutathione mediated mechanisms in tau hyper-phosphorylation.
Topics: Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Animals; Calpain; Cells, Cultured; Disease Models, Animal; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Maze Learning; Mice, Inbred C57BL; Molecular Sequence Data; Nerve Tissue Proteins; Neurons; Peptide Fragments; Phosphorylation; Rats, Sprague-Dawley; S-Nitrosoglutathione; tau Proteins | 2015 |
Blocking a vicious cycle nNOS/peroxynitrite/AMPK by S-nitrosoglutathione: implication for stroke therapy.
Topics: Adenylate Kinase; AMP-Activated Protein Kinase Kinases; Animals; Brain; Brain Ischemia; Disease Models, Animal; Infarction, Middle Cerebral Artery; Male; Neurons; Neuroprotective Agents; Nitric Oxide Synthase Type I; Peroxynitrous Acid; Phosphorylation; Protein Serine-Threonine Kinases; Random Allocation; Rats, Sprague-Dawley; Reperfusion Injury; S-Nitrosoglutathione; Stroke | 2015 |
S-nitrosoglutathione reduces tau hyper-phosphorylation and provides neuroprotection in rat model of chronic cerebral hypoperfusion.
Topics: Analysis of Variance; Animals; Brain; Brain Ischemia; Calpain; Chronic Disease; Cyclin-Dependent Kinase 5; Disease Models, Animal; Glycogen Synthase Kinase 3; Neuroprotective Agents; Phosphorylation; Rats; S-Nitrosoglutathione; Synaptosomes; tau Proteins; Tyrosine | 2015 |
Targeting the nNOS/peroxynitrite/calpain system to confer neuroprotection and aid functional recovery in a mouse model of TBI.
Topics: Animals; Brain; Brain Injuries; Calpain; Disease Models, Animal; Male; Mice, Inbred C57BL; Motor Activity; Neurons; Neuroprotective Agents; Nitric Oxide Synthase Type I; Peroxynitrous Acid; Phosphorylation; Random Allocation; Recovery of Function; S-Nitrosoglutathione | 2016 |
In Situ Microparticles Loaded with S-Nitrosoglutathione Protect from Stroke.
Topics: Animals; Blood Pressure; Disease Models, Animal; Injections, Subcutaneous; Male; Microspheres; Neuroprotective Agents; Platelet Aggregation; Rats; Rats, Wistar; S-Nitrosoglutathione; Stroke; Telemetry | 2015 |
Inhibition on the S-nitrosylation of MKK4 can protect hippocampal CA1 neurons in rat cerebral ischemia/reperfusion.
Topics: Animals; Brain Ischemia; CA1 Region, Hippocampal; Caspase 3; Disease Models, Animal; Dizocilpine Maleate; Indazoles; Male; MAP Kinase Kinase 4; Neurons; Phosphorylation; Rats; Rats, Sprague-Dawley; Reperfusion; S-Nitrosoglutathione; Time Factors | 2016 |
Topical HPMC/S-Nitrosoglutathione Solution Decreases Inflammation and Bone Resorption in Experimental Periodontal Disease in Rats.
Topics: Administration, Topical; Alveolar Bone Loss; Animals; Disease Models, Animal; Gingiva; Hypromellose Derivatives; Inflammation; Interleukin-1beta; Male; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Periodontal Diseases; Rats; Rats, Wistar; Receptor Activator of Nuclear Factor-kappa B; S-Nitrosoglutathione; Solutions; Tartrate-Resistant Acid Phosphatase; Tumor Necrosis Factor-alpha | 2016 |
Neuroprotective Effects of Inhibiting Fyn S-Nitrosylation on Cerebral Ischemia/Reperfusion-Induced Damage to CA1 Hippocampal Neurons.
Topics: Animals; Disease Models, Animal; Dizocilpine Maleate; HEK293 Cells; Hippocampus; Humans; Male; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type I; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-fyn; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; S-Nitrosoglutathione; Signal Transduction | 2016 |
Alteration of blood clot structures by interleukin-1 beta in association with bone defects healing.
Topics: Animals; Biomechanical Phenomena; Blood Coagulation; Disease Models, Animal; Fibrin; Fibrinolysis; Fracture Healing; Hematoma; Humans; Interleukin-1beta; Microscopy, Electron, Scanning; Rats; Rats, Inbred F344; S-Nitrosoglutathione; Thrombosis | 2016 |
GSNO promotes functional recovery in experimental TBI by stabilizing HIF-1α.
Topics: Animals; Brain; Brain Injuries; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Gene Expression; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Motor Skills; Neuroprotective Agents; Protein Stability; Random Allocation; Rats, Sprague-Dawley; Recognition, Psychology; Recovery of Function; S-Nitrosoglutathione | 2018 |
GOSPEL: a neuroprotective protein that binds to GAPDH upon S-nitrosylation.
Topics: 2',5'-Oligoadenylate Synthetase; Animals; Binding, Competitive; Brain; Carrier Proteins; Cells, Cultured; Disease Models, Animal; Embryo, Mammalian; Excitatory Amino Acid Agonists; Glyceraldehyde-3-Phosphate Dehydrogenases; Green Fluorescent Proteins; Humans; Mice; Mice, Knockout; Molecular Weight; MPTP Poisoning; Mutation; N-Methylaspartate; Nerve Tissue Proteins; Neurons; Neuroprotective Agents; Nitric Oxide Synthase Type I; Nuclear Proteins; Protein Binding; Protein Transport; RNA, Messenger; RNA, Small Interfering; S-Nitrosoglutathione; Transfection; Two-Hybrid System Techniques; Ubiquitin-Protein Ligases | 2009 |
A novel role of prostaglandin E2 in neuropathic pain: blockade of microglial migration in the spinal cord.
Topics: Adenosine Triphosphate; Animals; Cell Movement; Cerebral Cortex; Cinnamates; Dinoprostone; Disease Models, Animal; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Hyperalgesia; Indazoles; Intramolecular Oxidoreductases; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Knockout; Microglia; Neuralgia; Neurons; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type I; Prostaglandin-E Synthases; S-Nitrosoglutathione; Spinal Cord; Spinal Nerves | 2011 |
S-nitrosoglutathione supplementation to ovalbumin-sensitized and -challenged mice ameliorates methacholine-induced bronchoconstriction.
Topics: Administration, Inhalation; Aerosols; Animals; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Inflammation; Lung; Male; Methacholine Chloride; Mice; Mice, Inbred C57BL; Mucin 5AC; Ovalbumin; S-Nitrosoglutathione; Tracheotomy | 2011 |
Discovery of potent and novel S-nitrosoglutathione reductase inhibitors devoid of cytochrome P450 activities.
Topics: Aldehyde Oxidoreductases; Animals; Asthma; Benzamides; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Imidazoles; Lung; Mice; Molecular Structure; Molecular Targeted Therapy; No-Observed-Adverse-Effect Level; Pyrroles; Receptors, Opioid, delta; S-Nitrosoglutathione; Structure-Activity Relationship | 2011 |
S-nitrosoglutathione decreases inflammation and bone resorption in experimental periodontitis in rats.
Topics: Alkaline Phosphatase; Alveolar Bone Loss; Alveolar Process; Animals; Anti-Inflammatory Agents; Biomarkers; Bone Resorption; Disease Models, Animal; Gingiva; Injections; Interleukin-1beta; Lipid Peroxidation; Matrix Metalloproteinase Inhibitors; NF-kappa B; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Oxidative Stress; Periodontitis; Peroxidase; Pharmaceutic Aids; Povidone; Rats; Rats, Wistar; S-Nitrosoglutathione; Sodium Chloride; Tumor Necrosis Factor-alpha | 2012 |
S-nitrosoglutathione prevents experimental cerebral malaria.
Topics: Animals; Blood Pressure; Brain; Disease Models, Animal; Glutathione; Heart Rate; Malaria, Cerebral; Mice; Mice, Inbred C57BL; Nitric Oxide Donors; Plasmodium berghei; S-Nitrosoglutathione | 2012 |
Stimulation of functional recovery via the mechanisms of neurorepair by S-nitrosoglutathione and motor exercise in a rat model of transient cerebral ischemia and reperfusion.
Topics: Analysis of Variance; Animals; Apoptosis; Brain Infarction; Brain-Derived Neurotrophic Factor; Caspase 3; Chromones; Disease Models, Animal; Drug Administration Schedule; Enzyme Inhibitors; Exercise Therapy; Gene Expression Regulation; Glial Fibrillary Acidic Protein; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Locomotion; Male; Morpholines; Neuroprotective Agents; Oncogene Protein v-akt; Phosphopyruvate Hydratase; Platelet Endothelial Cell Adhesion Molecule-1; Rats; Rats, Sprague-Dawley; Receptor, trkB; Recovery of Function; Reperfusion; S-Nitrosoglutathione; Severity of Illness Index; Time Factors | 2012 |
The inhibitory effect of S-nitrosoglutathione on blood-brain barrier disruption and peroxynitrite formation in a rat model of experimental stroke.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Edema; Carrier Proteins; Disease Models, Animal; E-Selectin; Endothelial Cells; Evans Blue; Functional Laterality; Infarction, Middle Cerebral Artery; Male; Matrix Metalloproteinase 9; Neoplasm Proteins; Neurons; Neuroprotective Agents; NF-kappaB-Inducing Kinase; Nitric Oxide; Nitrites; Nucleocytoplasmic Transport Proteins; Peroxynitrous Acid; Phosphopyruvate Hydratase; Protein Serine-Threonine Kinases; Protein Transport; Rats; Rats, Sprague-Dawley; S-Nitrosoglutathione; Statistics, Nonparametric; Time Factors; Tyrosine; Zonula Occludens-1 Protein | 2012 |
Protective role of S-nitrosoglutathione (GSNO) against cognitive impairment in rat model of chronic cerebral hypoperfusion.
Topics: Animals; Brain; Cell Line; Cells, Cultured; Chronic Disease; Cognition Disorders; Disease Models, Animal; Maze Learning; Mice; Neuroprotective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; S-Nitrosoglutathione | 2013 |
Effect of nitric oxide on the contractile function of rat reperfused skeletal muscle.
Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Male; Muscle Contraction; Muscle, Skeletal; Nitric Oxide; Nitric Oxide Donors; omega-N-Methylarginine; Rats; Rats, Inbred Lew; Reperfusion Injury; S-Nitrosoglutathione | 2002 |
Effect of S-nitrosoglutathione (GSNO) added to the University of Wisconsin solution (UW): I) Morphological alteration during cold preservation/reperfusion of rat liver.
Topics: Animals; Cold Temperature; Disease Models, Animal; Drug Therapy, Combination; Hepatectomy; Immunohistochemistry; Male; Organ Preservation; Organ Preservation Solutions; Random Allocation; Rats; Rats, Wistar; Reference Values; Reperfusion Injury; S-Nitrosoglutathione; Sensitivity and Specificity | 2001 |
S-Nitrosoglutathione reduces inflammation and protects brain against focal cerebral ischemia in a rat model of experimental stroke.
Topics: Animals; Apoptosis; Astrocytes; Blotting, Western; Brain Ischemia; Cell Line; Coculture Techniques; Cytokines; Disease Models, Animal; Endothelial Cells; Immunohistochemistry; In Situ Nick-End Labeling; Inflammation; Male; Mice; Microglia; Neuroprotective Agents; Permeability; Rats; Rats, Sprague-Dawley; Reperfusion Injury; S-Nitrosoglutathione; Stroke | 2005 |
Nanoparticle-induced platelet aggregation and vascular thrombosis.
Topics: Animals; Blood Platelets; Carotid Artery Thrombosis; Chlorides; Disease Models, Animal; Dose-Response Relationship, Drug; Epoprostenol; Ferric Compounds; Humans; Microscopy, Electron, Transmission; Microscopy, Phase-Contrast; Nanostructures; Nanotechnology; Nanotubes, Carbon; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Rats; Rats, Inbred WKY; S-Nitrosoglutathione; Signal Transduction | 2005 |
GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions.
Topics: Administration, Oral; Animals; Blood-Brain Barrier; Cell Adhesion; Cell Adhesion Molecules; Cell Line; Central Nervous System; Chemotaxis, Leukocyte; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Endothelial Cells; Female; Mice; Monocytes; NF-kappa B; Nitric Oxide Donors; Nitro Compounds; Rats; Rats, Inbred Lew; S-Nitrosoglutathione; Signal Transduction; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2007 |
S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161-180))-induced experimental autoimmune uveitis.
Topics: Administration, Oral; Animals; Autoimmune Diseases; Cytokines; Disease Models, Animal; Electroretinography; Eye Proteins; Male; Mice; Nitric Oxide Donors; Photoreceptor Cells; Polymerase Chain Reaction; Retina; Retinol-Binding Proteins; S-Nitrosoglutathione; Spleen; T-Lymphocytes; Uveitis | 2007 |
Acute physical exercise reverses S-nitrosation of the insulin receptor, insulin receptor substrate 1 and protein kinase B/Akt in diet-induced obese Wistar rats.
Topics: Adaptor Proteins, Signal Transducing; AMP-Activated Protein Kinase Kinases; Animals; Diet; Disease Models, Animal; Enzyme Inhibitors; Insulin Receptor Substrate Proteins; Insulin Resistance; Lysine; Male; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Obesity; Physical Conditioning, Animal; Protein Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Receptor, Insulin; S-Nitrosoglutathione; Signal Transduction | 2008 |
Nitric oxide donor improves healing if applied on inflammatory and proliferative phase.
Topics: Administration, Topical; Animals; Disease Models, Animal; Hydrogels; Male; Nitric Oxide Donors; Rats; Rats, Wistar; S-Nitrosoglutathione; Skin; Wound Healing; Wounds and Injuries | 2008 |
Increased nitric oxide synthase activity after canine cardiopulmonary bypass is suppressed by s-nitrosoglutathione.
Topics: Animals; Blood Gas Analysis; Cardiopulmonary Bypass; CD18 Antigens; Coronary Vessels; Disease Models, Animal; Dogs; Glutathione; Hemodynamics; Infusions, Intravenous; Intraoperative Period; Myocardium; Neutrophils; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroso Compounds; Platelet Aggregation Inhibitors; Postoperative Complications; Random Allocation; S-Nitrosoglutathione | 1999 |
The global regulator ArcA controls resistance to reactive nitrogen and oxygen intermediates in Salmonella enterica serovar Enteritidis.
Topics: Animals; Bacterial Outer Membrane Proteins; Cloning, Molecular; Culture Media; Detergents; Disease Models, Animal; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli Proteins; Gene Library; Genetic Testing; Heating; Hydrogen Peroxide; Hydrogen-Ion Concentration; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mutagenesis; Nitric Oxide Donors; Nitrogen; Oxidants; Plasmids; Reactive Oxygen Species; Repressor Proteins; S-Nitrosoglutathione; Salmonella enteritidis; Salmonella Infections; Sequence Analysis, DNA; Sodium Chloride; Sodium Dodecyl Sulfate; Sodium Nitrite; Virulence | 2002 |